Minglu Liang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Natural product bioactivities and synthesis 5
- Angiogenesis and VEGF in Cancer 5
- Signaling Pathways in Disease 3
-
- NF-κB Signaling Pathways 4
- Co-authors
- Kai Huang (36 shared papers)Wenjing Xu (9 shared papers)Cheng Wang (6 shared papers)Fengxiao Zhang (10 shared papers)Yiqing Li (3 shared papers)Shan Deng (3 shared papers)Zhangyin Ming (6 shared papers)Yang Liu (2 shared papers)
- Journals
- European Journal of Pharmacology (3 papers)Frontiers in Pharmacology (3 papers)Scientific Reports (2 papers)Phytotherapy Research (2 papers)Diabetes (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Minglu Liang
49 papers receiving 878 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 185
- Molecular Biology 441
- Biochemistry 34
- Immunology 118
- Pharmacology 47
Countries citing papers authored by Minglu Liang
This map shows the geographic impact of Minglu Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minglu Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minglu Liang more than expected).
Fields of papers citing papers by Minglu Liang
This network shows the impact of papers produced by Minglu Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minglu Liang. The network helps show where Minglu Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Minglu Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 107 | |
| 2 | 2020 | 55 | |
| 3 | 2017 | 49 | |
| 4 | 2016 | 39 | |
| 5 | 2018 | 38 | |
| 6 | 2019 | 33 | |
| 7 | 2022 | 32 | |
| 8 | 2020 | 29 | |
| 9 | 2015 | 29 | |
| 10 | A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma. | 2018 | 28 |
| 11 | 2014 | 27 | |
| 12 | 2022 | 26 | |
| 13 | 2020 | 24 | |
| 14 | 2020 | 24 | |
| 15 | 2019 | 24 | |
| 16 | 2018 | 23 | |
| 17 | 2019 | 22 | |
| 18 | 2019 | 21 | |
| 19 | 2017 | 20 | |
| 20 | 2020 | 19 |
About Minglu Liang
Minglu Liang is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Oncology and Physiology, having authored 52 papers that have together received 884 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (7 papers), Natural product bioactivities and synthesis (5 papers), PARP inhibition in cancer therapy (5 papers), Angiogenesis and VEGF in Cancer (5 papers), NF-κB Signaling Pathways (4 papers), Signaling Pathways in Disease (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Cancer Research (185 citations), Molecular Biology (441 citations), Biochemistry (34 citations), Immunology (118 citations) and Pharmacology (47 citations). Minglu Liang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kai Huang, Wenjing Xu, Cheng Wang, Fengxiao Zhang, Yiqing Li, Shan Deng, Zhangyin Ming, Yang Liu, Dan Huang and Xingwen Da. Their work appears in journals such as European Journal of Pharmacology, Frontiers in Pharmacology, Scientific Reports, Phytotherapy Research and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.